Professor Prof. Gus Gazzard

Prof. GUS GAZZARD MD MA(Cantab) MBBChir FRCOphth Gus Gazzard completed undergraduate and medical school training at Corpus Christi College, Cambridge University. He was made a Consultant in the Glaucoma Service at Moorfields Eye Hospital in 2009 after a Clinical Fellowship at Moorfields 2006-08 and a Research Fellowship with Prof Peng Khaw in Singapore 1999-2002, where he ran and established several clinical trials investigating the surgical treatments of glaucoma (including the Singapore-5FU and the ACLIPS trials, both published in Ophthalmology). He was recently appointed UCL Professor in Ophthalmology (Glaucoma Studies) at the Institute of Ophthalmology, University College London and is currently Director of the Glaucoma service at Moorfields. Gus’ interests in the drop-free treatments of glaucoma continue with his current research into selective laser trabeculoplasty (SLT) and Minimally Invasive Glaucoma procedures (‘MIGS’). He introduced the ‘Trabectome’ procedure to Moorfields and is training surgeons in the use of the Trabectome, iStent, Xen, InnFocus and Hydrus devices. Gus has established two large, 6-year studies of laser treatment in the UK and China; is collaborating with Johns Hopkins (US) on defining outcomes for Minimally Invasive Glaucoma surgeries and co-ordinating a number of Cochrane Collaboration reviews of the devices. In 2012 he established, as Chief Investigator, the 6 year NIHR-HTA funded (£1.7m) multi-centre LiGHT trial of selective laser trabeculoplasty which completed recruitment of 718 subjects in October 2014 – on target, on-time and accepted for publication, due in early 2019. He has since raised more than a further £500k to support this and other projects. Begun 2015 the sister trial, LiGHT-China, recently finished enrolment of 769 subjects in collaboration with Sun Yat Sen University, Guangzhou. Gus’ clinical research interests include angle closure glaucoma, selective laser trabeculoplasty, randomised controlled trials of glaucoma treatments and anterior segment imaging. He is also: collaborating on the TAGS trial of surgery for advanced glaucoma; a member of the EAGLE Study Group (an international multi-centre study of early lens extraction in angle-closure); on the advisory board for the ZAP trial (assessing preventative laser iridotomy); co-founder of the European Glaucoma Society Special Interest Group in Angle Closure and member of the EGS external-relations committee..

Glaucoma & Cataract  Minimally Invasive Glaucoma Procedures Tube Surgery  Trabeculectomy  Selective Laser Trabeculoplasty